Histogenics

News

US biotechs Ocugen and Histogenics have announced plans to merge, creating a specialist in drugs and gene therapies for ocular diseases.

News

Flagship Pioneering has formed a new AI-focused biotech company, called Etcelera, by combining the platforms of three firms from its portfolio.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.